BioPlan LOGO

"Average 2025 Facility Budget Hikes:

  • +5.6% for upstream cost-efficiency tools
  • +5.5% for downstream; topping all other budget line items"

539 pages of data and insights in

BioPlan's 22nd Annual Report and Survey


With 22 years of expert trend analysis, 200+ data-rich graphs and tables, in 539 comprehensive pages, you get biopharma's most comprehensive industry overview highlighting biomanufacturing trends and cutting-edge technologies.


  • Comprehensive Industry Overview: A complete look at the biopharma industry from experts, 203 global biopharma respondents, 116 suppliers from 21 countries.


  • Economic Impact & Budget Trends: Influence of the current economic environment on industry budgets and investment.


  • Innovation Adoption: Most in-demand bioprocessing innovations, adoptions over the past 22 years; continuous, automation, single-use and many more.


  • Downstream Purification Solutions: Detailed analysis of downstream purification problems and innovative solutions.


  • Bottlenecks & Capacity Management: Current and projected industry bottlenecks, capacity utilization, production levels, and strategies for resolution.


  • Production & Outsourcing Trends: Key biopharma outsourcing and landscape trends; international offshoring projections through 2030.


  • Process Performance Metrics: Insights into the range of titers, growth rates, and crucial data on batch failure rates and trends.


  • Single-use & Disposables: Rise in SUS adoption, spending, DSP applications, L&E's, increasing/restricting adoption, budgets, and vendor satisfaction.


  • Strategic Partnerships: Selecting a CDMO, outsourcing and in-sourcing trends, common problems and effective solutions.


  • Quality & Operational Excellence: The latest on quality management and Process Analytical Technology implementation.


  • Hiring Challenges & Growth: Hiring and employment growth, challenges and trends, supplier growth, and much more.

BioPlan Associates Inc.

Empowering Smarter Decisions - 30 Years of Unbiased, Data-driven Biopharma Market Analysis and Insights


For over 30 years BioPlan has been one of the most cited industry sources, delivering unbiased data, analysis, and custom strategy to the biopharmaceutical and life sciences community.


Contact us: +1 (301) 921-5979, info@bioplanassociates.com

LinkedIn  X